ORIC Pharmaceuticals GAAP EPS of -$0.38 misses by $0.02 (ORIC:NASDAQ)
· seekingalpha.com
ORIC Pharmaceuticals (ORIC) Q2 GAAP EPS -$0.38 misses by $0.02; cash/investments $387.6M funds operations into 2H 2028.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...